Objective Elder patients are likely to have higher disease complexity and more drug prescriptions of which are associated with a high incidence of adverse drug reactions (ADRs). This study is to investigate factors associated with ADRs occurrence, prognosis, and medical expenses among elderly inpatients. Design This study applied a case-control design. A total of 539 ADRs cases from a patient cohort containing 108,548 elderly inpatients during 2006-2012 were collected; 1854 non-ADR matched controls, a maximum of 1:5 matching by age, sex, principal diagnosis, were collected. Results This study found that admission department, number of comorbidities, and number of drug prescriptions before ADRs were associated with ADRs occurrence among elderly inpatients. ADRs severity was found as a significant prognostic factor among ADRs cases. The multivariate-adjusted odds ratio of 1.63(95% CI 1.36 -1.95) on poor prognosis was found as number of comorbidities increased. Patients prescribed with ≥11 drugs of a particular profile were at 2.45 (95% CI 1.40 -4.28) folds of poor prognosis than patients otherwise. ADRs caused an addition of US$ 1803.8, US$ 360.8, and 5.6 days in total medical expenses, drug expenses, and length of stay, among affected elderly inpatients, respectively. Conclusions This study demonstrated that the number of comorbidities and prescriptions of anticonvulsants, antipyretics, narcotic analgesics, tranquilizers, sedates & hypnotics, and other CNS drugs may play a significant role in ADRs occurrence and prognosis among elderly inpatients. The findings provide clues for future prescription modification and elder patient's quality and safety in geriatric care.
INTRODUCTION
As aging has become a worldwide phenomenon, geriatric health issues deserve more attention. Previous studies have shown that approximately 55%-98% of the elderly aged over 65 years have had two or more concurrent diseases. 1 Multimorbidity and physical frailty in older adults are associated with an elevated risk of death, disability, poor quality of life, and adverse drug reactions (ADRs). [2] [3] [4] Therefore, the interactive effects of multimorbidity and drug medications are in urgent need to be continually investigated. Several studies revealed that the incidence of ADRs in hospitalized elderly patients ranged from 6% to 26% in different countries. [5] [6] [7] The hospitalized older patients are usually frail and have comorbid conditions which magnify the complexity of health care needs that result in unavoidable multiple medication regimens. an appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment, or alteration of the dosage regimen, or withdrawal of the product. 19 Study data was extracted from the reporting system of the focal hospital. General variables included the admission department, the patient's age and gender, principal diagnosis, admission department, Charlson comorbidity index (CCI), 20 comorbidities in terms of number of secondary diagnoses, number of drugs prescribed before ADRs inception, and items of medical expenses, including the length of stay and the itemized cost for the medical orders. For non-ADRs cases, the number and classes of drugs prescribed within the same timespan upon admission contrasted to that of the matched ADRs case was calculated. ADRs related variables included suspicious drugs, affected organs, symptoms or syndromes of ADRs, the Naranjo score, 21 and the severity of the ADRs. The symptoms and signs of the ADRs were categorized into 13 groups according to the affected organs and systems (Appendix 1). The suspicious drugs causing ADRs were grouped into 15 classes, including others, according to their pharmacological and anatomic-physiological characteristics (Appendix 2). The identification of drugs was based on the different chemical names and coded by the Anatomical Therapeutic Chemical (ATC) classification system. 22 The prognoses of the study inpatients were recorded from discharge conditions, which were classified as poor (including deaths, discharge against medical advices in critical conditions, and continued hospitalization to ICU), and improved status (including recovery and outpatient follow-up).
Statistical methods
Descriptive statistics were used to examine the distribution of variables between the case group and the control group. Categorical variables are presented as frequency and percentage, whereas numerical variables were presented as the means and standard deviations. Univariate analyses were applied to determine the significance of the variables as preliminary information for further analyses. Categorical variables were analyzed using the chi-squared test to compare groups, whereas numerical variables were tested with two-sample t-tests between groups. Multiple logistic regression analysis was used to construct models for the occurrence and prognosis of ADRs. For the model selection, variables with p-value<0.2 were considered as candidates for multivariable analyses. A backward selection method was applied in this study. Odds ratio (OR) was calculated as strength of association in modeling ADRs occurrence and poor prognoses. A generalized linear model was applied to estimate the length of hospital stays and medical expenses, and the logarithmic transformation was performed with positive skewing. All statistical analysis was performed using SAS version 9.4 (Cary, North Carolina, USA).
Patient and public involvement
No patients or public were involved in the study.
RESULTS
The study collected 539 ADRs cases from the elderly inpatients at the medical center during the period 2006-2011. A total of 1854 matched control elderly inpatients without ADRs were density-sampled from the same medical center according to the hospitalization time of the cases. The mean age of the ADR cases and controls was similarly close to 76 years old (Table 1) . Male inpatients accounted for 55.8% of the study samples. The highest incidence of ADRs among the elderly inpatients was in the department of internal medicine (57.7%), followed by those of surgery (15.8%), oncology (11.9%), and infectious diseases (8.5%). A significant association was found between admission department and ADRs occurrence (p=0.0079). The top three frequently seen principal diagnoses in ADR cases were respiratory diseases (21.7%), circulation system (16.9%), and neoplasms (13.0%). The ADR cases had an increased number of comorbidities, and F o r p e e r r e v i e w o n l y 4 13.2% of the cases had five or more comorbidities, as opposed to 0.6% in the control group (p<0.0001). The distribution of CCI was not associated with ADRs occurrence (Table 1) .
The Naranjo score, as rated by senior pharmacists, was recorded to reflect the causality of ADR cases. A total of 451 cases (83.7%) scored ≤ 4, 83 cases (15.4%) scored 5-8, and 5 cases (0.9%) scored ≥ 9 ( Table 2) . A total of 317 (58.8%) cases were rated as moderate severity followed by 192 (35.6%) as mild, and 30 (5.6%) as severe consequence. A "poor prognosis", including death, discharge against medical advices in critical conditions, and continued hospitalization to ICU, and as identified according to discharge notes, was reported more frequently in patients experiencing an ADR (18.7%) than the control patients (11.5%) (p<0.0001). Both ADRs and non-ADRs groups were prescribed around 15 classes of drugs before ADRs inception, and during the whole hospital stay, even though a significant difference was shown between two groups (p=0.0069 and p<0.0001, respectively). The number of drug prescriptions before ADRs was higher in the ADRs group (106.16) than in the non-ADRs group (98.96) (p<0.0001). Higher medical expenses were accrued in the ADRs group compared with the non-ADRs control group. The length of hospital stay for the ADRs inpatients averaged 30.8 days higher than an average of 16.9 days in the control group (p<0.0001). An analysis of total medical expenses showed that medical expenses were US$ 9531.3 for the ADRs inpatients compared with US$ 4108.9 for the control group (p<0.0001). The expenses of drug medications were US$ 2276.4 in the ADRs group, which was significantly higher than in the control group (US$ 817.0; p<0.0001) ( Table 2 ).
The department of oncology had higher likelihood of ADRs occurrence (OR=1.71; 95% CI=1.10-2.67) than the reference department, infectious department (Model 1, Table 3 ). A dose-response relationship was found between the number of comorbidities and ADRs occurrence, with an odds ratio of 1.43 (95% CI=1.29-1.57) for each increment of comorbidities. The likelihood of ADRs occurrence was significantly increased as number of drug prescriptions before ADRs increased (OR=1.02, 95% CI=1.01-1.02, for each increment).
ADRs cases being prescribed ≥11 number of anticonvulsants, antipyretics, narcotic analgesics, tranquilizers, sedates & hypnotics, or other CNS drugs were at higher risk in having poor prognosis (OR=2.45, 95% CI=1.40-4.28) than that of <11 prescriptions. Degree of ADRs severity was positively associated with poor prognoses (p<0.05, test for monotonic trend) in which ADRs cases with moderate and severe severity were at higher risk of poor prognosis (OR=1.95, 95% CI=1.12-3.42 and OR=2.74, 95% CI=0.98-7.72, respectively) than were those with mild severity (Model 2, Table 3 ).
Multivariable-adjusted estimates of economic impacts, including total medical expenses, drug expenses, and length of hospital stay, by ADRs severity are presented in Figure 2 . The relative elevations of total medical expenses and drug expenses followed a dose-response relationship with degree of ADRs severity and a significantly monotonic trend was observed. Additional US$1512.7-4141.6 and US$ 317.9-593.8 cost derived from incremental ADR severity were found in total medical expenses and drug expenses, respectively, during the whole hospitalization (data not shown). The relative elevation of length of hospital stay was higher among ADRs cases (data not shown; folds of elevation=1.45; 95% CI=1.34-1.56) as opposed to non-ADRs.
DISCUSSION
The ADRs among elderly population became an important health care issue, particularly for the Asia-Pacific countries with fast growing aged population. Although relatively lower percentage of ADRs cases were observed in this study population due to attributes of ethnicity and health care system, the findings provide clues for improving patient safety and reducing medical cost while are valuable for the professional society in the world. This study identified factors associated with the occurrence and consequences of ADRs among the elderly inpatients. The study found that patient's admission department, number of comorbidities, and number of drug prescriptions before ADRs, were associated with both occurrence and prognosis of ADRs. In addition to the association between polypharmacy and ADRs, the study has demonstrated that increased number of CNS-related drug prescriptions and degree of ADRs severity were associated with patient's poor prognosis. Furthermore, a dose-response relationship was found between ADRs severity and total medical expenses and drug expenses. This study enriched the body of knowledge of drug-related problems for the elderly inpatients in Asia.
The effects of age-related physiological alterations, as well as the presence of comorbidity and polypharmacy have been previously reported. 8 23 24 Aging involves gradual impairments in multiple organs, and physiological changes such as decreases in both hepatic and renal blood flow, and glomerular filtration rate that would lead to less favorable pharmacokinetics consequences. 23 25 Interactions between altered kinetic and reduced homeostatic response also complicate pharmacodynamics in elderly individuals. Therefore, modified prescription guidelines should be considered for elderly patients. In addition, the current therapeutic decisions usually focus on specific diseases and seldom take into consideration of complicated comorbid conditions. Together with all these factors make elderly patients at greater risk of ADRs. In the present study, 76.5% of the elderly inpatients had four or more comorbidities of which interactions with the number of drug prescriptions were found. This study also found a synergistic effect between the number of comorbidities and ADRs occurrence on poor prognosis, which suggests that patients' physiological responses to drugs and disease complexity are inter-related. While most researches demonstrated specific drug classes as a cause of ADRs, [26] [27] [28] our study found, in particular, the numerous prescriptions of CNS-related drugs to be likely to cause poor prognosis among the elderly inpatients. A conjecture of elderly specific health problems and high risk characteristics is made for future geriatric care. Poor prognosis of the elderly patients was associated with the severity of ADRs of which depicts vulnerability of the elderly to adverse drug events. Prevention and intervention of the elderly's misusage of poly pharmacy may be as important as preventing infectious diseases such as pneumonia in the future.
The Charlson comorbidity index (CCI) and number of comorbidities have been used in parallel to examine the association with ADRs occurrence in this study. However, the CCI was not significantly associated with ADRs occurrence in this analysis. The possible reasons of the inconsistency may be attributable to the CCI calculation by only including selected diagnoses, rather than all present diseases. Instead of applying CCI, several studies documented the impacts of specific comorbidities, such as renal insufficiency, congestive heart failure, and diabetes on the risk of ADRs. 7 29 30 Unfortunately, there is no universal algorithm so far. Albeit, the easier way of counting the comorbidities is currently accepted and applicable. Onder et al. have demonstrated that patients with more than four comorbidities had an elevated risk of ADR occurrence. 6 Another study has also demonstrated a positive association between the number of secondary diagnoses and the risk of developing cutaneous ADRs among inpatients. 10 Our study demonstrated consistent findings that the number of comorbidities to be feasible in predicting ADRs occurrence and even the subsequent prognosis. This is a critical indicator in modifying medical treatments for the elderly population.
This study confirmed the positive association between the number of drugs prescribed before ADR and ADR inception. 6 31 Various studies have demonstrated that the number or classes of drug prescriptions were positively associated with the occurrence of ADRs among various inpatients, with the odds ratios ranging from 1.09 to 3.3. 5 31-33 The present study has demonstrated a significant association between the number, but not the classes, of drugs prescribed before ADR and ADRs occurrence (Model 1, Table 3 ). The underlying mechanisms could be high drug dose exposure or a high chance of possible drug-drug interactions, even in the same drug class. In our analysis, a relative lower strength of association was found in the number of drugs (OR=1.02) compared to the number of comorbidities (OR=1.43), which was consistent with previous observations that patient physiological and functional characteristics are more important in predicting both adverse and beneficial outcomes. 34 Previous articles have reported the prevalence of multimorbidity among elderly population in north America and Australia ranging from 53.9% to 98.7%. 35 36 To manage the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r p e e r r e v i e w o n l y 6 coexistent diseases, multiple medications are a common practice of which ADRs risk is simultaneously elevated.
The oncology department was identified as the admitting department with the greatest likelihood for patients to develop ADRs. Previous studies have suggested that some antineoplastic agents are associated with a higher risk of developing ADRs. 6 According to our analysis of drug classes that caused ADRs, the top three classes are antibiotics (293, 54.36%), anticonvulsants, antipyretics, narcotic analgesics, tranquilizers, sedates & hypnotics, and other CNS drugs (55, 10.20%), and antineoplastic agents (50, 9.28%) (Appendix 2). Except antineoplastic agents, the other two classes of drugs are commonly prescribed across different admission departments, including oncology department. The potentially harmful drug-drug interactions may increase the likelihood of ADRs among complicated patients in oncology department.
In regard to adverse impacts of ADRs on prognosis, the mortality rate of the elderly inpatients with ADRs was calculated to be 14.8%, which was 1.6 folds of the controls (9.1%) ( Table 2 ). Based on multivariable-adjusted logistic regression, age, principal diagnosis, admission department, comorbidities, and specific medications are associated with development of poor prognosis. Interestingly, ADRs severity instead of ADRs occurrence was a significant factor of poor prognosis during the hospitalization, which is coherent with other researches. 10 37 ADRs contributed to significant raises in total medical expenses, drug fees, and length of stay. Additional US$ 1803.8 per hospitalization of total medical expenses and US$ 360.8 per hospitalization of drug fees were attributable to ADRs occurrence (data not shown). In addition, an extra 5.6 days of hospital stay was found among the elderly ADRs inpatients (data not shown), which is higher than that of previous studies showing up to 36% or 3.8 days of additional length of stay due to ADRs among adult inpatients. [37] [38] [39] Polypharmacy is commonly seen in the elderly patients due to multicomorbidity conditions. Special caution should be taken when prescribing for the elderly with non-antibiotics anti-infective agent, anticonvulsants, antipyretics, narcotic analgesics, tranquilizers, sedates & hypnotics, and other CNS drugs. Rearrangement of prescription dosage plus interval of these medicines is expected to reduce chance of ADRs and improve care quality.
LIMITATIONS
Although this study is a representative and comprehensive ADRs database analysis in the largest medical center in Taiwan, some limitations merit our attention. First, the study did not differentiate between preventable and non-preventable ADRs, which might influence risk factors. Second, the number and classes of drug prescriptions, regarding generic or brand names are different across health care systems, which may affect results of risk analyses in ADR occurrence and poor prognosis. Third, caution should be made when applying the results to other ethnic groups with different genetic backgrounds, patient profile, and health care systems. Finally, the medical characteristics of outpatients may differ from the present inpatient findings in terms of disease complications, drug prescriptions, and patient's compliance. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Strengths and limitations of this study  A significant association was found between the number, but not the classes, of drugs prescribed before
ADRs occurrence.  The number of comorbidities played a greater role in developing poor prognosis from ADRs in older inpatients than did the number of prescribed drugs.  Patients prescribed ≥ 11 drugs showed 2.45-fold greater risk in developing poor prognosis.  We should be cautious when applying the results to other ethnic groups with different genetic backgrounds, patient profile, and health care systems.  The medical characteristics of outpatients may differ from the present inpatient findings in terms of disease complications, drug prescriptions, and patient's compliance.
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INTRODUCTION
As ageing has become a worldwide phenomenon, geriatric health issues deserve more attention. Previous studies have shown that approximately 55%-98% of patients aged over 65 years have had two or more concurrent diseases. 1 Multimorbidity and physical frailty in older adults are associated with an elevated risk of death, disability, poor quality of life, and adverse drug reactions (ADRs). [2] [3] [4] Therefore, the interactive effects of multimorbidity and drug medications need to be continually investigated.
Several studies have revealed that the incidence of ADRs in hospitalized older patients ranged from 6% to 26% in different countries. [5] [6] [7] Hospitalized older patients are usually frail and have comorbid conditions that magnify the complexity of health care needs and result in unavoidable multiple medication regimens. As a result, accompanied with advancing age, the dysregulation of body systems and changes in pharmacokinetics and pharmacodynamics make older patients more susceptible to adverse drug effects. 7 8 Using different study populations, the organ systems most frequently affected by ADRs were the dermatological, gastrointestinal, cardiovascular, endocrine and metabolic, and renal systems. 5 9-11 A previous study revealed that an additional US177.4 billion spent in the United States was attributable to ADRs in the year 2000. 12 The prolonged length of stay and extra medical costs caused by an ADR was approximately 1.2 -3.8 days and accounted for $US 2284 -$US 5456, respectively. 13 Many studies have documented risk factors, including age, gender, comorbidities, polypharmacy, inappropriate use of drugs, poor cognitive function, alcohol intake, length of stay, and depression, as associated with ADRs. [14] [15] [16] [17] [18] However, life-style, food style, medical-seeking behaviours, and health care systems in Asian countries are quite different from western countries. In this sense, the genetic characteristics and susceptibility to drugs, and prescription behaviours were also different in various ethnic groups. For example, the study setting is under a compulsory national health insurance system in which patients are usually seeking multiple medical assistances including western medicine, herbal medicine, and food supplements at an affordable cost. Therefore, the characteristics and factors associated with ADRs and the subsequent medical and economic impacts are anticipated to be different.
ADRs contribute to lengthened hospital stays, increased medical expenses, and most importantly, decreased care quality and safety. 5 9 11-13 Because older inpatients are more likely to have multiple conditions and chances for ADRs, ADRs issues in older individuals are worthy of attention. Although many studies have documented risk factors of ADRs occurrence, most of the study samples were from western populations. 7 14 Due to the differences in ethnicity and health care systems, an investigation of Asian ethnicities with a large series of cases is warranted. This study aimed to examine factors associated with ADRs, and the impacts of these factors on prognosis and medical expenses among older inpatients in an Asian population.
METHODS

Reporting system and data files
The data were collected from Chang Gung Memorial Hospital (CGMH), a 4,000-bed medical centre located in northern Taiwan that serves 3.2 million outpatients, 160,000 emergency patients, and 120,000 inpatients (approximately 1.2 million inpatient days) each year. CGMH initiated a reporting system for adverse drug reactions in 2002 and mandated all medical personnel to report any suspected ADRs cases. After a series of administrative interventions, the reporting system is reliable and comprehensive. An ADRs case was approved by senior pharmacists and possible challenges were made to confirm the causality of the reported ADRs and a suspicious drug. The number of reported ADRs cases was found to plateau and stabilize by the end of 2004. 10 Under review, monitoring, and approval by the Institute Review Board (IRB #102-0710C), this study retrospectively collected all reported ADRs cases from Jan 1, 2006 to Dec 31, 2012 as primary sources from study subjects. During this study period, there were a total 108,548 older inpatients at the study hospital. Among them, a total of 670 in-hospital newly reported ADRs cases, an incidence rate of 0.62%, were found. The matched controls were selected according to their similar age ( 3 years), and identical sex and ± 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
reported ADRs older inpatients were eligible and a total of 1,854 matched controls were collected in this nested case-control study (Figure 1 ). No significant difference was found in distributions of sex, age, principal diagnosis, Naranjo score, and Charlson comorbidity index between 539 matched and 131 non-matched ADRs cases (data not shown). The sample size was calculated and satisfied under OR=2.0 with a statistical power of 0.8, assuming a significance level of 0.05 using Power Analysis and Sample Size (PASS 11, NCSS 2010).
Research variables
In this study, an ADR was defined according to the definition made by Edwards and Aronson. 19 An ADR is an appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment, alteration of the dosage regimen, or withdrawal of the product. 19 Study data was extracted from the reporting system of the focal hospital. Exposure variables included the admission department, patient's age and sex, principal diagnosis, Charlson comorbidity index (CCI), 20 comorbidities in terms of the number of secondary diagnoses, and number of drugs prescribed before ADRs inception. Additionally, the Naranjo score was assigned by senior pharmacists trained and standardized before practice. The Charlson score was calculated retrospectively from the claim database. For non-ADRs cases, the number and classes of drugs prescribed within the same timespan upon admission compared to that of the matched ADRs case was calculated. ADRs related variables included suspicious drugs, affected organs, symptoms or syndromes of ADRs, the Naranjo score, 21 and the severity of the ADRs. The symptoms and signs of the ADRs were categorized into 13 groups according to the affected organs and systems (Appendix 1). The suspicious drugs causing ADRs were grouped into 15 classes, including others, according to their pharmacological and anatomic-physiological characteristics (Appendix 2). The identification of drugs was based on the different chemical names and coded by the Anatomical Therapeutic Chemical (ATC) classification system. 22 The primary outcomes of this study are ADRs occurrence and the prognosis of the study inpatients. The prognoses were recorded from discharge conditions, which were classified as poor (including deaths, discharge against medical advices in critical conditions, and continued hospitalization to ICU) and improved status (including recovery and outpatient follow-up). Additional medical expenses during hospitalization and the length of hospital stay were the secondary outcomes.
Statistical methods
Descriptive statistics were used to examine the distribution of the variables between the case and control groups. Categorical variables are presented as the frequency and percentage, whereas numerical variables were presented as the means and standard deviations. Univariate analyses were applied to determine the significance of the variables as preliminary information for further analyses. Categorical variables were analysed using the chi-squared test to compare groups, whereas numerical variables were tested with twosample t-tests between groups. Multiple logistic regression analysis was used to construct models for the occurrence and prognosis of ADRs. For the model selection, variables with p-value<0.2 were considered as candidates for multivariable analyses. A backward selection method was applied in this study. The odds ratio (OR) was calculated as the strength of association in modelling the ADRs occurrence and poor prognoses. A generalized linear model was applied to estimate the length of hospital stays and medical expenses, and a logarithmic transformation was performed with positive skewing. All statistical analysis was performed using SAS version 9.4 (Cary, North Carolina, USA).
Patient and public involvement
There was no patient or public involvement in the study. 
RESULTS
The study collected 539 reported ADRs cases from older inpatients at the medical centre during the period from 2006-2011. A total of 1854 matched control older inpatients without reported ADRs were densitysampled from the same medical centre according to the hospitalization time of the cases. The mean age of the ADRs cases and controls was close to 76 years old (Table 1) . Male inpatients accounted for 55.8% of the study samples. The highest incidence of reported ADRs among the older inpatients was in the department of internal medicine (57.7%), followed by those in surgery (15.8%), oncology (11.9%), and infectious diseases (8.5%). A significant association was found between the admission department and the reported ADRs occurrence (p=0.0079). The top three frequently seen principal diagnoses in reported ADRs cases were respiratory diseases (21.7%), circulation system (16.9%), and neoplasms (13.0%). The reported ADRs cases had an increased number of comorbidities, and 13.2% of the cases had five or more comorbidities, as opposed to 0.6% in the control group (p<0.0001). The CCI distribution was not associated with the reported ADRs occurrence (Table 1) .
Regarding the ADRs characteristics, the Naranjo score, as rated by senior pharmacists, was recorded to reflect the causality of the reported ADRs cases. A total of 451 cases (83.7%) were scored as ≤ 4, 83 cases (15.4%) as 5-8, and 5 cases (0.9%) ≥ 9 ( Table 2) . A total of 317 (58.8%) cases were rated as moderate severity followed by 192 (35.6%) as mild, and 30 (5.6%) as severe. The outcome measure of poor prognosis, including death, discharge against medical advice in critical conditions, and continued hospitalization to ICU, as identified according to discharge notes, was reported more frequently in patients experiencing ADRs (18.7%) than the control patients (11.5%) (p<0.0001). Both reported ADRs and non-ADRs groups were prescribed approximately 15 classes of drugs before ADRs inception during their entire hospital stay, though a significant difference was shown between the two groups (p=0.0069 and p<0.0001, respectively). The number of drug prescriptions before ADRs was higher in the ADRs group (106.16) than in the non-ADRs group (98.96) (p<0.0001). Higher medical expenses were accrued in the reported ADRs group compared with the non-ADRs control group. The length of hospital stay for the reported ADRs inpatients averaged 30.8 days longer than the average of 16.9 days for the control group (p<0.0001). Analysis of the total medical expenses showed that medical expenses were US$ 9531.3 for ADRs inpatients compared with US$ 4108.9 for the control group (p<0.0001). Drug medication expenses were US$ 2276.4 in the reported ADRs group, which was significantly higher than that in the control group (US$ 817.0; p<0.0001) ( Table 2) .
The multivariate analyses showed that the department of oncology had a higher likelihood of reporting ADRs occurrence (OR=1.71; 95% CI=1.10-2.67) than the reference department, infectious disease department (Model 1 in Table 3 ). A dose-response relationship was found between the number of comorbidities and the reported ADRs occurrence, with an odds ratio of 1.43 (95% CI=1.29-1.57) for each increment of comorbidity. The likelihood of reported ADRs occurrence was significantly increased as the number of drug prescriptions before ADRs increased (OR=1.02, 95% CI=1.01-1.02, for each increment).
Furthermore, reported ADRs cases being prescribed ≥11 anticonvulsants, antipyretics, narcotic analgesics, tranquilizers, sedates & hypnotics, or other CNS drugs were at a higher risk of having poor prognosis (OR=2.45, 95% CI=1.40-4.28) than those prescribed <11 prescriptions. The degree of reported ADRs severity was positively associated with poor prognoses (p<0.05, test for monotonic trend) in which reported ADRs cases with moderate and severe severity were at a higher risk of poor prognosis (OR=1.95, 95% CI=1.12-3.42 and OR=2.74, 95% CI=0.98-7.72, respectively) than those with mild severity (Model 2 in Table 3 ).
Multivariable-adjusted estimates of economic impacts, including total medical expenses, drug expenses, and length of hospital stay, by reported ADRs severity are presented in Figure 2 . Odds ratios were used to demonstrate the relative increase in medical consumption. Total medical expenses and drug expenses followed a dose-response relationship with the degree of reported ADRs severity and a significantly monotonic trend was observed. The additional US$1512.7-4141.6 and US$ 317.9-593.8 cost derived from incremental 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y   5 reported ADRs severity were found for the total medical expenses and drug expenses, respectively, during hospitalization (data not shown). The relative increase in the length of hospital stay was higher among reported ADRs cases (data not shown; fold elevation=1.45; 95% CI=1.34-1.56) as opposed to non-ADRs controls.
DISCUSSION
ADRs have become an important health care issue in the older population, particularly for the fast-growing aged population in Asia-Pacific countries. Although a relatively lower percentage of ADRs cases were observed in this study population due to attributes associated with ethnicity and the health care system, the findings provide clues for improving patient safety and reducing medical costs that are valuable for a professional society in the world. This study identified factors associated with the occurrence and consequences of ADRs among older inpatients. The study found that the patient's admission department, number of comorbidities, and number of drug prescriptions before ADRs were associated with both the occurrence and prognosis of ADRs. In addition to the association between polypharmacy and ADRs, the study has demonstrated that an increased number of CNS-related drug prescriptions and the degree of ADRs severity were associated with poor prognosis in patients. Furthermore, a dose-response relationship was found between ADRs severity and total medical expenses and drug expenses. This study enriched the body of knowledge on drug-related problems for older inpatients in Taiwan.
The effects of age-related physiological alterations, as well as the presence of comorbidity and polypharmacy, have been previously reported. 8 23 24 Ageing involves gradual impairments in multiple organs and physiological changes such as decreases in both hepatic and renal blood flow, and glomerular filtration rates that lead to less than favourable pharmacokinetic consequences. 23 25 Interactions between altered kinetics and reduced homeostatic response also complicate pharmacodynamics in older individuals. Therefore, modified prescription guidelines should be considered for older patients. Additionally, current therapeutic decisions usually focus on specific diseases and seldom consider complicated comorbid conditions. Altogether, these factors make older patients at a greater risk for ADRs. In the present study, 76.5% of older inpatients had four or more comorbidities, in which interactions with the number of drug prescriptions were found. This study also found a synergistic effect between the number of comorbidities and ADRs occurrence on poor prognosis, which suggests that patients' physiological responses to drugs and disease complexity are interrelated. While most studies demonstrated specific drug classes as a cause of ADRs, [26] [27] [28] our study, in particular, found that numerous CNS-related prescriptions are likely to cause poor prognosis among older inpatients. A conjecture of older specific health problems and high-risk characteristics is made for future geriatric care. Poor prognosis in older patients was associated with ADRs severity, which depicts the vulnerability of older patients to adverse drug events. Prevention and intervention in the misuse of poly-pharmacy in older patients may be as important as preventing infectious diseases such as pneumonia in the future.
The Charlson comorbidity index (CCI) and number of comorbidities have been used in parallel to examine the association with ADRs occurrence in this study. However, the CCI was not significantly associated with ADRs occurrence in this analysis. The possible reasons for the inconsistency may be attributable to the CCI calculation only including selected diagnoses rather than all present diseases. Instead of applying CCI, several studies documented the impacts of specific comorbidities, such as renal insufficiency, congestive heart failure, and diabetes on the risk of ADRs. 7 29 30 Unfortunately, there is no universal algorithm to date. Albeit, an easier way of counting the comorbidities is currently accepted and applicable. Onder et al. have demonstrated that patients with more than four comorbidities had an elevated risk of ADRs occurrence. 6 Another study has also demonstrated a positive association between the number of secondary diagnoses and the risk of developing cutaneous ADRs among inpatients. 10 Our study demonstrated consistently that the number of comorbidities can predict ADRs occurrence and the subsequent prognosis. This is a critical indicator in modifying medical treatments for the older population.
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ADRs inception. 6 31 Various studies have demonstrated that the number or classes of drug prescriptions were positively associated with the occurrence of ADRs among various inpatients, with the odds ratios ranging from 1.09 to 3.3. 5 31-33 The present study has demonstrated a significant association between the number, but not the classes, of drugs prescribed before ADRs and ADRs occurrence (Model 1 in Table 3 ). The underlying mechanisms could be high drug dose exposure or a high chance of possible drug-drug interactions, even in the same drug class. In our analysis, a relatively lower strength of association was found for the number of drugs (OR=1.02) compared to the number of comorbidities (OR=1.43), which was consistent with previous observations that patient physiological and functional characteristics are more important for predicting both adverse and beneficial outcomes. 34 Previous articles have reported the prevalence of multimorbidity among older populations in North America and Australia ranging from 53.9% to 98.7%. 35, 36 To manage coexistent diseases, multiple medications are a common practice, and the risk of ADRs is simultaneously elevated. The oncology department was identified as the admitting department with the greatest likelihood for patients to develop ADRs. Previous studies have suggested that some antineoplastic agents are associated with a higher risk of developing ADRs. 6 According to our analysis of drug classes that caused ADRs, the top three classes are antibiotics (293, 54.36%); anticonvulsants, antipyretics, narcotic analgesics, tranquilizers, sedates and hypnotics, and other CNS drugs (55, 10.20%); and antineoplastic agents (50, 9.28%) (Appendix 2). Aside from antineoplastic agents, the other two classes of drugs are commonly prescribed across different admission departments, including the oncology department. Whether potentially harmful drug-drug interactions may increase the likelihood of ADRs in complicated patients in the oncology department is worthy of further investigations.
With regard to the adverse impacts of ADRs on prognosis, the mortality rate of older inpatients with ADRs was calculated to be 14.8%, which was 1.6-fold higher than the controls (9.1%) ( Table 2 ). Based on multivariable-adjusted logistic regression, age, principal diagnosis, admission department, comorbidities, and specific medications are associated with the development of poor prognosis. Interestingly, ADRs severity instead of ADRs occurrence was a significant factor of poor prognosis during hospitalization, which is consistent with other studies. 10 37 ADRs contributed to significant increases in total medical expenses, drug fees, and length of stay. Moreover, US$ 1803.8 and US$ 360.8 per hospitalization in total medical expenses and drug fees, respectively, were attributable to ADRs occurrence (data not shown). Additionally, an extra 5.6 days of hospital stay was found among older ADRs inpatients (data not shown), which is higher than that observed in previous studies showing up to 36% or 3.8 days of additional length of stay due to ADRs among adult inpatients. [37] [38] [39] Polypharmacy is commonly seen in older patients due to multicomorbidity conditions. Special caution should be taken when prescribing older patients with non-antibiotics anti-infective agent, anticonvulsants, antipyretics, narcotic analgesics, tranquilizers, sedates and hypnotics, and other CNS drugs. Rearrangement of prescription dosage plus the intervals of these medicines is expected to reduce the chance of ADRs and improve care quality. Although we have reported a lower percentage of ADRs in this study, lower ADRs were also found in previous studies from the same population. 10 11 We believe that there are a number of reasons that cause the low ADRs prevalence in this inpatient cohort. First, we have an information alarm system to assist physicians to reconfirm and avoid ADRs while prescribing a potential drug. Second, the ethnicity difference and cautious prescribing behaviour may cause a low ADRs in this medical centre. Third, although we have incentives for physicians, nurses, and pharmacists to report ADRs, there might be under reporting in practice.
LIMITATIONS
Although this study is a representative and comprehensive ADRs database analysis at the largest medical centre in Taiwan, some limitations merit our attention. First, the study did not differentiate between preventable and non-preventable ADRs, which might influence the factor inference. Second, the number and 
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